Skip to main content
CriticalFDAfda-F-0885-2021UNDECLARED ALLERGEN

Wavy Lay s Original Potato Chips UPC 0 28400 04380 9 packaged in flexible bag

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Units Affected
36
Recall Date
August 11, 2021
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0885-2021.

May contain undeclared milk

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0885-2021.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Frito-lay, Inc. Headquarters or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0885-2021.

Frito-Lay, Inc. Headquarters

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Frito-lay, Inc. Headquarters Recall FAQ

Frito-lay, Inc. Headquarters is the subject of a snacks & candy safety report: Wavy Lay s Original Potato Chips UPC 0 28400 04380 9 packaged in flexible bag. The notice was published on August 11, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 36 units are potentially affected.